No CRS summary available for this bill.
This section requires covered entities making nucleic acid sequences available in interstate or foreign commerce to verify buyer identities, establish purchase purposes, screen for covered sequences on the Secretary’s list, apply risk-based refusal criteria, notify the Secretary of potential national security threats, conduct independent compliance assessments, and retain records for at least five years. It directs the Secretary to issue implementation and enforcement guidance within 180 days and one year of enactment, establish notification and coordination processes, consult stakeholders on best practices, and submit annual reports to Congress for six years beginning two years after enactment.